eMethods. Additional Methodology
Customize your JAMA Network experience by selecting one or more topics from the list below.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Angraal S, Zachariah AG, Raaisa R, et al. Evaluation of Internet-Based Crowdsourced Fundraising to Cover Health Care Costs in the United States. JAMA Netw Open. 2021;4(1):e2033157. doi:10.1001/jamanetworkopen.2020.33157
Online fundraising platforms have emerged as means to raise money for charity. Patients can also access these platforms to receive charitable contributions to support their health care costs. We sought to evaluate the use of a popular fundraising platform to cover health care–related costs, the medical conditions involved with these fundraisers, and their geographic distribution in the US.
This serial cross-sectional study was exempted from review by the University of Missouri Kansas City institutional review board because it did not contain patient data. Participant consent was waived because all data were publicly available.
We extracted data from the GoFundMe website, from its inception in May 2010 through December 2018. A looping web scraper tool was created1 to extract the following data: text body of the fundraiser, self-tagged category, geotagged location, date of creation, target amount sought (in US dollars), and total amount raised (in US dollars). We ran the program in April 2019. Fundraisers self-tagged as medical were included.
We classified fundraisers by key conditions that pose high morbidity in the US: cancer, cardiovascular conditions, neurological conditions, and trauma or injury.2 For classification, clinical descriptors from the main text body of these fundraising campaigns were extracted using a pretrained machine learning model,3 and campaigns were then categorized into disease categories using a natural language processing algorithm through biomedical word vectors.4 A manual abstraction of 1000 randomly selected fundraisers found a 90.1% classification accuracy. Geographic tags were used to assess state-level distribution, standardized to 2010 US Census data. Finally, using linear regression, we compared the state-level prevalence of online fundraisers with the Charitable Giving Index to assess how charity patterns correlate with online fundraisers.5 Two-tailed P < .05 was considered statistically significant. Data analyses were performed using Python software version 3.6 (Python Software Foundation) and R statistical software version 3.6.0 (R Project for Statistical Computing) from July 2019 to February 2020 (eMethods in the Supplement).
Of the 1 056 455 fundraisers on the online platform in the US between May 2010 and December 2018, 281 881 (26.7%) were created to cover health care–related costs, collectively seeking $10 285 738 233. As of April 2019, $3 663 935 620 had been raised. There was a large increase in the use of medical fundraisers over time; from 42 fundraisers in 2010 to 119 373 in 2018 (a mean increase of 14 916 fundraisers per year) (Figure 1A). In 2010, $717 125 was sought, which increased to $4 663 513 572 in 2018 (mean increase of $582 849 556 per year).
A total of 98 352 fundraisers (34.9%) were for cancer, 53 861 (19.1%) for trauma/injury, 48 963 (17.4%) for neurological conditions, and 10 143 (3.6%) for cardiovascular conditions. The number of online medical fundraisers increased for all 4 conditions over the study period (Figure 1B). For cancer, $4 481 980 170 was sought ($45 571 per fundraiser). For trauma/injury, $1 609 046 833 was sought ($29 874 per fundraiser). Neurological and cardiovascular conditions sought a total of $1 212 452 440 and $287 113 426 ($24 763 and $28 307 per fundraiser, respectively).
Maine had the highest prevalence of online medical fundraisers (139.4 fundraisers per 100 000 population), followed by Alaska (137.2 fundraisers per 100 000 population) (Figure 2). Mississippi had the lowest prevalence of online medical fundraisers (54.6 fundraisers per 100 000 population). The states with higher Charitable Giving Index had a higher prevalence of online fundraisers (β = 0.072; P = .03; β=0.072).
From May 2010 through December 2018, more than $10 billion was sought through online medical fundraisers in the US, with more than $3 billion raised. Cancer represented the most common medical condition for which funding was sought, followed by trauma/injury.
Cancer therapy is expensive, and out-of-pocket costs for newly diagnosed patients with cancer frequently represent 23% to 63% of their household income.6 Our study suggests that many patients are using online fundraisers to cope with the high financial burden due to cancer.
This study had some limitations. Although our study does not contain patient-specific clinical data and included only 1 fundraising platform, thereby representing the lower bound on the true use of such mechanisms, it highlights a unique aspect of financial toxicity of health care.
Online fundraising to cover health care–related expenditures has grown substantially over the past years. These results highlight how many people are relying on the charity of others for raising money to cover health care costs.
Accepted for Publication: November 18, 2020.
Published: January 11, 2021. doi:10.1001/jamanetworkopen.2020.33157
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Angraal S et al. JAMA Network Open.
Corresponding Author: John A. Spertus, MD, MPH, Health Outcomes Research, St Luke’s Mid America Heart Institute, University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO 64112 (firstname.lastname@example.org).
Author Contributions: Dr Angraal had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Krumholz and Spertus contributed equally as senior authors, listed alphabetically.
Concept and design: Angraal, Khera, Spertus.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Angraal, Zachariah, Raaisa.
Critical revision of the manuscript for important intellectual content: Angraal, Khera, Rao, Krumholz, Spertus.
Statistical analysis: Angraal, Zachariah, Khera.
Supervision: Rao, Spertus.
Conflict of Interest Disclosures: Dr Krumholz reported receiving personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, Siegfried & Jensen Law Firm, Arnold & Porter Law Firm, Martin/Baughman Law Firm, National Center for Cardiovascular Diseases, Beijing, and F-Prime; serving as cofounder of HugoHealth, a personal health information platform; serving as cofounder of Refactor Health, an enterprise healthcare AI-augmented data management company; receiving contracts from Centers for Medicare & Medicaid Services, through Yale New Haven Hospital, to develop and maintain measures of hospital performance; and receiving grants from Medtronic and the Food and Drug Administration, Medtronic and Johnson and Johnson, and Shenzhen Center for Health Information outside the submitted work. Dr Spertus is a consultant for United Healthcare, Novartis, Bayer, AstraZeneca, Janssen, Amgen, and Myokardia; has copyrights for the Kansas City Cardiomyopathy Questionnaire, Seattle Angina Questionnaire and Peripheral Artery Questionnaire; is on the Board of Directors of Blue Cross Blue Shield of Kansas City; and holds an equity interest in Health Outcomes Sciences. No other disclosures were reported.
Funding/Support: Dr Rao is supported by the National Science Foundation (NSF CNS-1747751).
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Create a personal account or sign in to: